The elevation of all circulating EMPs under investigation, namely CD31+/42−/AV+, CD144+/AV+, and CD62e+/AV+, in the hypercholesterolemic group supports their potential role as surrogate biomarkers of endothelial dysfunction. The gene discussed is PECAM1; the disease is endothelial dysfunction.